2-pyrrolidones as ep4 receptor agonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/06 (2006.01)

Patent

CA 2502914

This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors of Formula (I), their use or a formulation thereof in the treatment of glaucoma and other conditions which are related to elevated intraocular pressure in the eye of a patient. This invention further relates to the use of the compounds of this invention for mediating the bone modeling and remodeling processes of the osteoblasts and osteoclasts.

L'invention concerne des agonistes sélectifs efficaces du sous-type EP¿4? des récepteurs E2 de prostaglandine, l'utilisation de ces agonistes ou de préparations à base de ceux-ci dans le traitement du glaucome et d'autres états associés à une pression intra-oculaire élevée dans l'oeil d'un patient. L'invention concerne également l'utilisation des composés de l'invention dans la médiation des processus de modelage et de remodelage des ostéoblastes et des ostéoclastes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

2-pyrrolidones as ep4 receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-pyrrolidones as ep4 receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-pyrrolidones as ep4 receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1843738

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.